Policies

Medicare Coverage Database (MCD)

The draft LCDs are available on the CMS MCD website:

Proposed LCDs

When there are Proposed Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Proposed under development, not yet released for comment
C = Proposed LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Proposed LCD Comments to:

Mail:
Noridian Medicare JF Part B
Attention: Proposed LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

X
 
Proposed LCD and LCA Title Release Date of Proposed LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin

Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin		 08/04/22 09/17/22 A View 01/19/2023 View
Cataract Surgery in Adults

Billing and Coding: Cataract Surgery in Adults		 02/09/23 03/25/23 E      
Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease

Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease		 02/09/23 03/25/23 E      
MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma

Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma		 07/07/22 08/20/22 E      
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis 10/06/22 11/19/22 E      
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia

Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia		 04/28/22 06/11/22 F View 04/13/23 View
MolDX: Plasma-Based Genomic Profiling in Solid Tumors

Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors		 01/20/22 03/05/22 F View 11/20/22 View
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer		 07/14/22 08/27/22 E      
Sacroiliac Joint Injections and Procedures

Billing and Coding: Sacroiliac Joint Injections and Procedures		 09/29/22 11/12/22 A View 03/18/23 View
Transcranial Magnetic Stimulation (TMS)

Billing and Coding: Transcranial Magnetic Stimulation (TMS)		 02/09/23 03/25/23 E      
Urine Drug Testing

Billing and Coding: Urine Drug Testing		 04/27/23 06/12/23 C      

 

When a "Draft" LCD becomes "Final/Future," go to the Future LCDs page to view a specific future LCD.

  • View All Future LCDs by state. Within the table, each state selection will redirect you to the MCD on the CMS website. Note: All LCDs for JE states are the same.

 

Last Updated Fri, 12 May 2023 17:15:28 +0000